Clinical Trials
13 trialsNCT03471078 2023-09-28
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Sobi, Inc.
Phase 3 Completed
NCT02055781 2021-11-18
PAC326
CTI BioPharma
Phase 3 Terminated
NCT01773187 2020-09-29
Pacritinib Versus Best Available Therapy to Treat Myelofibrosis
CTI BioPharma
Phase 3 Terminated
NCT01663441 2020-09-16
A Phase â…¢a Study of Genetically Modified Recombinant Human Interleukin-11
Beijing Northland Biotech. Co., Ltd.
Phase 3 Completed
NCT02389621 2018-10-30
L-PLUS 2
Shionogi Inc.
Phase 3 Completed
NCT02093325 2017-10-24
A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia
Chang Gung Memorial Hospital
Phase 3 Unknown
NCT01444417 2017-02-09
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
Amgen
Phase 3 Completed
NCT02244658 2016-04-20
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Shandong University
Phase 3 Unknown
NCT00074763 2012-08-02
Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00501345 2012-08-01
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00039910 2007-05-04
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
Pfizer
Phase 3 Completed
NCT00151866 2007-02-27
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
Sanquin Research & Blood Bank Divisions
Phase 3 Completed
NCT00037791 2006-11-09
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
Pfizer
Phase 3 Completed